Ratiograstim® 48 Mio. I.E./0,8 ml Injektions- oder Infusionslösung - ratiopharm GmbH
TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-K Annual Report Filed 2023-02-10
PDF] Multidisciplinary approach to evaluating immunogenicity of biosimilars: lessons learnt and open questions based on 10 years' experience of the European Union regulatory pathway | Semantic Scholar
Teva Pharmaceutical Industries logo in transparent PNG and vectorized SVG formats
Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor | SpringerLink
Filgrastim-Teva Inj Lös 30 Mio E/0.5ml Fertspr 0.5 ml auf Rezept kaufen | Amavita
Teva Pharmaceutical Industries logo in transparent PNG and vectorized SVG formats